Navigation Links
U.S. Patent Office Issues Sixth Patent Covering 'Zero-Footprint' Medical Image Viewers to Heart Imaging Technologies, LLC

DURHAM, N.C., May 1, 2012 /PRNewswire/ -- Heart IT, the global leader that pioneered the first FDA approved zero footprint medical imaging workstation, WebPAX®, announced today the award of its sixth patent covering "zero-footprint" medical image viewing technologies. "Zero-footprint" technologies allow health care professionals to view medical images using any computing platform with a standard Internet web browser.

This includes Microsoft's Internet Explorer, Mozilla's Firefox, Apple's Safari, and Google's Chrome on Windows-based desktop and laptop PCs in addition to Macintosh-based desktops and laptops. Further, WebPAX® enables users of mobile devices to access medical images through standard browsers on Apple's iPad and iPhone, as well as all Google Android tablets and cell phones. Without "zero-footprint" technologies, medical images can only be viewed by installing proprietary software that is different for each web browser, each operating system, and each hardware device.

U.S. Patent Number 8166381 issued on April 24, 2012. Heart IT's "zero footprint" intellectual property portfolio also includes five previously-issued U.S. Patents: 6934698, 7457656, 7668835, 7958100, and 8055636. HeartIT's intellectual property coverage for its issued patents extends through the year 2025. Additional related patents are pending review by the U.S. Patent and Trademark Office.

About Heart IT:

Founded in 2000 and headquartered near North Carolina's Research Triangle Park, Heart IT is a global leader in the medical image web enablement field. Their flagship product, WebPAX®, was the world's first FDA approved zero footprint medical image workstation. It provides web-based medical image management technology and services to health care systems, large hospitals and private clinics as well as drug and device companies sponsoring multi-center clinical trials. Worldwide, WebPAX® systems currently provide secure web browser access to over one billion medical images. For more information visit our website at

"WebPAX" is a registered trademark of Heart Imaging Technologies, LLC. All other trademarks acknowledged.

* 300dpi image download for media:

This release was issued on behalf of the above organization by Send2Press(R), a unit of Neotrope(R).  

SOURCE Heart Imaging Technologies
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
2. Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
3. Essential Medical Dismisses Patent Case against Masimo and Cercacor
4. Watson Confirms Favorable District Court Ruling in Generic Sanctura XR® Patent Suit
5. Inovio Receives U.S. Patent for SynCon® H1N1 Influenza Universal Vaccine
6. Ampio Strengthens Patent Protection for Lead Drug Ampion™
7. Opto-Acoustic Transducers Remove Blockages. ICAP Patent Brokerage Announces for Auction Important Patents for Medical Techniques and Devices That Perform Blockage Removal Using Lasers, Ultrasonics, and Fiber Optics
8. Watson Confirms NIASPAN(R) Patent Challenge
9. Watson Confirms BYSTOLIC(R) Patent Challenge
10. Patent and Trademark Trends 2011: Thomson Reuters Evaluates the State of Global IP
11. Patented Protection Against Counterfeit Pharmaceuticals and Retail Fraud. ICAP Patent Brokerage Announces for Auction a Patented System for Verification of Purchase and Product Legality
Post Your Comments:
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host ... webcast on Friday, November 3, 2017, beginning at 7:00 ... approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... performance and guidance for 2018, Hill-Rom executives will also ... performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)...  EpiVax, Inc., a leader in the fields ... announced the launch of EpiVax Oncology Inc., a ... cancer vaccines. EpiVax has provided $500,000 in seed ... technologies to the new precision immunotherapy venture. Gad ... as Chief Executive Officer. Gad brings over 25 ...
(Date:9/19/2017)... --  ZirMed Inc ., a recognized leader in cloud-based revenue ... been ranked #1 by its users for the seventh consecutive ... Survey. ZirMed was recognized as the top-ranked end-to-end revenue cycle ... over 200 beds and holds one of the longest #1 ... ...
Breaking Medicine Technology:
(Date:10/12/2017)... , ... October 12, 2017 , ... ... now treating sleep apnea using cutting-edge Oventus O2Vent technology. As many ... sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer significant ...
(Date:10/12/2017)... ... 12, 2017 , ... IsoComforter, Inc. ( ), one of ... innovative new design of the shoulder pad. The shoulder pad provides optimal support ... your pain while using cold therapy. By utilizing ice and water that is circulated ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... that we intend to develop to enable prevention of a major side effect ... hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health ... interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), an ... education, today announce a new strategic alliance. , As CPEN’s strategic partner, ...
Breaking Medicine News(10 mins):